Pharma: Page 56
-
PharmaVoice Team/PharmaVoice
Emerging Market: China
Whether it is partnering, acquisitions, or the expansion of operations, China spells opportunity for the pharmaceutical industry. Increasingly, global pharmaceutical companies are either expanding their own operations within China or choosing to partner with China-based companies. According to IM...
By PharmaVoice Team • Jan. 26, 2011 -
PharmaVoice Team/PharmaVoice
Digital Marketing: Dare to be Different
Research shows creativity is one of the most important components of a successful campaign, however, our experts say there are several other elements behind a campaign that need to be present to make the best of what digital media have to offer. Among them are matching the audience with the most ...
By PharmaVoice Team • Jan. 26, 2011 -
Explore the Trendline➔
Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Timothy HAYES Bayer Adds Global Business Development Oversight Timothy Hayes, currently senior VP and region head for Bayer HealthCare’s Consumer Care division in North America, has assumed the additional responsibility of leading the business unit’s global business developmen...
By PharmaVoice Team • Sept. 28, 2010 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: Tibco Unveils Solution for Accelerating Drug Development C3i Offers Subscription-Based Data Management Hosting Medidata Adds Supply Management, Source Document Verification Solutions Chiltern Solution Consolidates...
By PharmaVoice Team • Aug. 26, 2010 -
PharmaVoice Team/PharmaVoice
The CREATIVES
Let the Force be Creative These rock stars of healthcare advertising are infusing their creative passion and energy into healthcare communications across all media. There is no off switch for Jamie Cobb, Executive Creative Director at MicroMass Communications; he is always on, always thinking, a...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
The MARKETERS
The next big idea lies in pushing beyond comfort zones, and Dan Bobear fearlessly tackles issues head-on and challenges all who work with him to feed their minds to achieve marketing excellence. In leading his team at Palio, he breaks down the unpredictable and channels his colleagues’ energy a...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
The Researchers & SCIENTISTS
A Diagnosis of Type 1 diabetes at the age of 6 and an early passion for science and research have propelled Randy Anderson, Ph.D., to become a force in the fight against the disease. Dr. Anderson has been making inroads into unraveling the mysteries of the disease since his senior-year zoology c...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Generics coming home to roost… By now, everyone in the pharmaceutical industry realizes that billions and billions of sales of branded products are going away, and the impact of this is going to be huge. According to IMS Health, the 5% to 8% compound annual growth rate during the next five years ...
By Taren Grom • May 24, 2010 -
PharmaVoice Team/PharmaVoice
The Package Deal
PharmaVOICE Container or labeling of which, without authorization, bears the trademark, trade name, or other identifying mark, imprint, or device, or any likeness thereof, of a drug manufacturer, pro cessor, packer, or distributor other than the per son or persons who in fact manufactured, pro ce...
By Elizabeth Pena • Jan. 18, 2010 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Dr. Jack GOLDSTEIN Chiron Names Blood Testing Division President Chiron Corp. has named Jack Goldstein, Ph.D., president of Chi ron’s blood testing division. Dr. Goldstein is responsible for the commercial operations of Chiron’s blood testing business, based in Emeryville, Calif. He a...
By PharmaVoice Team • Jan. 13, 2010 -
PharmaVoice Team/PharmaVoice
Raise Your Voice: Letters
Missed opportunity I applaud the fact that PharmaVOICE has highlighted the importance of the new PhRMA Voluntary Marketing Code, but I would be remiss if I didn’t ask: “Where in this article is the discussion about the benefit of the new code to the patient?” In reading through this 11 page artic...
By PharmaVoice Team • Jan. 13, 2010 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh DIRECTOR OF SALES Darlene Kwiatkowski CONTRIBUTING EDITORS Virginia Kirk Denise Myshko Elisabeth Pena Kim Ribbink Alex Robinson Lynda Sears Copyright 2002 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Volume Two, Numb...
By Taren Grom • Jan. 13, 2010 -
PharmaVoice Team/PharmaVoice
The IRS vs. Independent Contractors
Many pharmaceutical companies are now using independent contractors in increasing numbers; in many cases, these contractors are former employees. What started off as a trickle a few years ago has become a torrent. Quite often, former employees — whether they left voluntarily or not — end up back ...
By Andrew E. Schultz • Jan. 11, 2010 -
PharmaVoice Team/PharmaVoice
The Value of Innovation
BY ALEX ROBINSON Let’s stop complaining about spending on prescription drugs,” Alan Holmer, president of the Phar maceutical Research and Manufacturers of Ameri ca (PhRMA) told an audience in April. “In fact, let’s hope that prescription drug spending goes up — not down.” Critics are quick to poi...
By Alex Robinson • Jan. 11, 2010 -
PharmaVoice Team/PharmaVoice
E-Media
NEW ELECTRONIC AND WEB BASED APPLICATIONS, SITES, AND TECHNOLOGIES MDchoice.com Inc. has unveiled a new marketing platform that allows hospitals, clinics, and physician groups to offer their own private label online healthcare information services. The platform offers health information ranging f...
By PharmaVoice Team • Jan. 11, 2010 -
PharmaVoice Team/PharmaVoice
Pharmaceutical Manufacturing Under Scrutiny
Across the board — from labeling and marketing, to clinical trials, to manufacturing processes — regulators are becoming more active in safeguarding the public and ensuring the safety of pharmaceuticals. Even before the news broke regarding Genzyme Corp.’s recent virus and contamination problems ...
By PharmaVoice Team • Dec. 28, 2009 -
PharmaVoice Team/PharmaVoice
Felix Theeuwes — Durect Results
Results With more than 30 years experience in developing innovative drugdelivery technologies, Dr.Felix Theeuwes as chairman and chief scientific officer of Durect, is directing the startup company with the goal of commercializing pharmaceutical systems that . BY KIM RIBBINK Photos: Scott Lewis C...
By PharmaVoice Team • Nov. 4, 2009 -
PharmaVoice Team/PharmaVoice
Pharmacy Direct
In an effort to make it EASIER FOR PATIENTS to fill their prescriptions, some doctors’practices are bringing in VENDING MACHINE STYLE dispensers. BY JEAN LAWRENCE When patients leave Abbott Northwestern hospital in Minneapolis, they can now head straight home rather than to the drugstore. They al...
By Jean Lawrence • Nov. 4, 2009 -
PharmaVoice Team/PharmaVoice
Animal Farm — The Promise of Xenotransplantation
Animal Farm BY DENISE MYSHKO NO ONE WOULD DISPUTE THAT THERE IS A SHORTAGE OF HEARTS, KIDNEYS, OR LIVERS FOR THOSE WHO REQUIRE A NEW ONE. Last year in the United States alone, 6,000 people died while awaiting an organ transplant. Campaigns to increase organ donation have been somewhat successful ...
By PharmaVoice Team • Nov. 4, 2009 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Andrew R.J. BONFIELD Bristol Myers Squibb Appoints New Senior VP and Chief Financial Officer Andrew R.J. Bonfield joins Bristol Myers Squibb as senior VP and chief financial officer. Mr. Bonfield, 39, served most recently as executive director of finance at BGGroup Plc., a multibillio...
By PharmaVoice Team • Nov. 3, 2009 -
PharmaVoice Team/PharmaVoice
Pharma Outlet
There is a movement afoot to reform the system enacted to address patent disputes between pioneer drug developers and their generic drug competitors. When this system, referred to as the HatchWaxman Act, was passed in 1984, it was intended to balance the competing interests of pioneer pharmaceuti...
By Barbara Carter • Nov. 2, 2009 -
PharmaVoice Team/PharmaVoice
CROs: Mission Possible
MISSION ANALYSTS … JOSEPH AVELLONE,M.D. President and CEO,Veritas Medicine Inc., Cambridge, Mass.;Veritas Medicine is a leading provider of Internet and patientdatabase services to identify and recruit patients into appropriate clinical trials ALFRED G.CHILDERS,PH.D. Principal and president of ad...
By PharmaVoice Team • Nov. 2, 2009 -
PharmaVoice Team/PharmaVoice
Image is Everything
Research into the human genome and intricate studies of disease states are opening the door to personalized therapy. But for those therapies to reach the right target audience, accurate and early diagnosis of disease are essential. Amersham Health, which develops and markets diagnostic pharmaceut...
By PharmaVoice Team • Nov. 2, 2009 -
PharmaVoice Team/PharmaVoice
Standardized Development Metrics
The use of standardized performance metrics by drug developers — CROs and sponsors — to reduce clinical development time and to improve deliverables is more essential than ever for success. BY ROBIN ROBINSON Many companies have attempted to come up with ways to better manage the clinical-trial pr...
By PharmaVoice Team • March 31, 2009 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh CONTRIBUTING EDITORS Diane Hoffman Virginia Kirk Denise Myshko Kim Ribbink Deborah Ruriani Lynda Sears Copyright 2002 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Volume Two, Number One PharmaVoice is published eight...
By PharmaVoice Team • March 10, 2009
Previous
